
OrthoTreat is a preclinical stage company developing ModulX® - a first-in-class, ready-to-use intraoperative injectable therapy designed to improve fracture healing and reduce the risk of delayed union, non-union, and implant failure. ModulX® combines two synergistic small molecules in a controlled-release hydrogel that modulates both bone formation and resorption (OsteoRegulation). Seamlessly integrated into standard fixati...